The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery

PURPOSE: The fibrinogen/albumin ratio (FAR) is increasingly considered as a potential biomarker for predicting prognosis in various malignant tumors, whereas the value of the FAR in predicting the recurrence-free survival (RFS) in patients with combined hepatocellular cholangiocarcinoma (cHCC-CCA) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiake, Li, Shaochun, Feng, Ye, Zhang, Jie, Peng, Youduo, Wang, Xiaohong, Wang, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143788/
https://www.ncbi.nlm.nih.gov/pubmed/35637941
http://dx.doi.org/10.2147/CMAR.S361462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143788/
https://www.ncbi.nlm.nih.gov/pubmed/35637941
http://dx.doi.org/10.2147/CMAR.S361462

Ejemplares similares